Zinzino Reports 20 Percent Revenue Growth for July

The group's growth was fueled by significant gains in North American and Central European markets, which posted increases of 36 percent and 28 percent respectively during the month. While expansion remains robust in newer territories like South America, where revenue jumped 388 percent to SEK 3.9 million, established regions saw mixed results. Nordic markets recorded a 6 percent decline, and the Baltics saw a 13 percent drop compared to July 2025.

Faun Pharma, the group’s manufacturing arm, contributed SEK 2.5 million to the total monthly figure, reflecting a 14 percent increase. Year-to-date, the parent company has maintained a consistent 22 percent growth rate compared to the same period last year. These figures underscore a broader trend of geographical diversification for the company, as international markets increasingly offset slower activity in domestic Northern European sectors.